aspartic protease

This term is a highly specialized biochemical designation used almost exclusively in scientific literature, pharmacology, and molecular biology. It describes a specific class of enzymes defined by their catalytic mechanism, where two aspartate residues facilitate the cleavage of peptide bonds. Because it is a technical term, it lacks a casual or metaphorical equivalent and is always used in a formal, academic register.

In a clinical or research context, it is frequently discussed in relation to protease inhibitors, which are drugs designed to block these enzymes to prevent viral replication, particularly in the treatment of HIV/AIDS.